ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ERES East Resources Acquisition Company

10.85
0.00 (0.00%)
Pre Market
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
East Resources Acquisition Company NASDAQ:ERES NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 10.85 13.45 13.52 0 01:00:00

ERT to Present at the UBS 20th Annual Global Healthcare Services Conference on February 8, 2010

01/02/2010 10:30pm

PR Newswire (US)


East Resources Acquisition (NASDAQ:ERES)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more East Resources Acquisition Charts.
PHILADELPHIA, Feb. 1 /PRNewswire-FirstCall/ -- ERT (NASDAQ:ERES), announced today that Dr. Michael J. McKelvey, the Company's President and CEO, and Keith Schneck, the Company's Executive Vice President and CFO, are scheduled to present at the UBS 20th Annual Global Healthcare Services Conference at 3:30 PM EST on February 8, 2010 in New York City. Interested parties may access the presentation by visiting the Company's corporate website at http://www.ert.com/. The webcast may also be accessed at http://cc.talkpoint.com/ubsx001/020810a_ke/?entity=33_YR2H1UU. The webcast will be available via replay for 90 days. About ERT Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a global provider of technology and services to the biopharmaceutical, medical device, and related industries. The Company is the market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The Company also provides technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development. Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company's ability to obtain new contracts, variability in size, scope and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. DATASOURCE: ERT CONTACT: Keith Schneck, CFO, +1-215-972-0420, Web Site: http://www.ert.com/

Copyright

1 Year East Resources Acquisition Chart

1 Year East Resources Acquisition Chart

1 Month East Resources Acquisition Chart

1 Month East Resources Acquisition Chart